NCT00935662View on ClinicalTrials.gov

A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses

PHASE1CompletedINTERVENTIONAL

Enrollment

119

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Healthy Men

Interventions

DRUG

AZD8329

Oral solution, single ascending doses

DRUG

Placebo

Oral solution, placebo

Trial Locations (2)

Unknown

Research Site, Linköping

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY